All Biotech News

List of articles in category All Biotech News
Title	Published Date
Orchard Therapeutics Appoints Frank Thomas as Chief Financial Officer and Chief Business Officer	01/17/2018
Batavia Biosciences Teams Up with International Consortium to Support Polio Eradication	01/16/2018
BioNTech Announces Results from Two More Studies Demonstrating the Benefits of Breast Cancer Subtyping Using Mammatyper®	01/15/2018
TFS International Appoints New Chief Executive Officer	01/10/2018
WACKER Obtains FDA Approval to Manufacture the Drug Substance in Retavase®, a Thrombolysis Medication by Chiesi	01/09/2018
ANTABIO Announces Key Executive Appointments	01/05/2018
Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing Sites in San Diego and Bristol	01/04/2018
Orchard Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference	12/22/2017
rfxcel Approved as a Technically Certified Connection Provider for EMVO	12/21/2017
Orchard Therapeutics Announces $110M Series B Financing to Advance Transformative Gene Therapy Pipeline	12/20/2017
Agendia and Bluebee Partner to Bring New NGS-Based MammaPrint® BluePrint® Breast Cancer Kit to Market	12/19/2017
Orchard Therapeutics and Généthon Announce Gene Therapy Alliance in X-linked Chronic Granulomatous Disease	12/15/2017
FDA Grants Orphan Drug Designation to Zytoprotec's Novel Dialysis Fluid	12/14/2017
Thrombolytic Science Announces the Appointment of Annalisa Jenkins, MBBS, FRCP, as a Non-Executive Board Member	12/14/2017
Key Executives Join the rfxcel Team to Drive Global Growth	12/13/2017
Agendia: Key Studies Presented at the San Antonio Breast Cancer Symposium Demonstrate the Important Role of MammaPrint® for Patient Pre-Selection, Cost-Effectiveness and For Younger Patients	12/12/2017
Dr. Hitto Kaufmann of Sanofi-Aventis and Dr. Eliana Clark of Biogen to Deliver Plenary Keynote Presentations at CHI’s Bioprocessing Summit Europe	12/12/2017
BioGenes Establishes Scientific Advisory Board	12/12/2017
NorthSea Therapeutics Secures €25 Million Funding for Clinical Development of Promising NASH Drug	12/12/2017
Genomic Health: New Validation Shows Oncotype DX Breast Recurrence Score® Test Predicts Clinical Response to Neoadjuvant Hormonal Therapy to Improve Surgical Outcomes in Certain Patients with Large Tumors	12/11/2017
Sartorius Stedim Biotech Launches New Versions of Data Analytics Software Solutions	12/07/2017
Agendia and UZ Leuven Partner to Co-Validate MammaPrint® BluePrint® Breast Cancer Risk of Recurrence and Molecular Subtyping Kit Ahead of European Launch	12/07/2017
Vetter Receives Corporate Health Award’s Recognition of Excellence	12/06/2017
Agendia Collaborates with Prestigious Cancer Center, Institut Curie, for MammaPrint® BluePrint® Breast Cancer Kit Co-Validation Study	12/05/2017
Polyganics Awarded €1.2 Million to Complete Clinical Development of Dura Sealant Patch	12/01/2017
New Data at the San Antonio Breast Cancer Symposium Demonstrate the Value of MammaPrint® and BluePrint® Across Breast Cancer Patient Populations	11/30/2017
Selvita Promotes Edyta Jaworska to the Management Board to Strengthen Development in Integrated Drug Discovery Services	11/30/2017
Orchard Therapeutics Announces Expansion of Technical Operations in California	11/30/2017
Second Sartorius Research Xchange Forum Focuses On Regenerative Medicine and Cell Therapy	11/29/2017
Agendia’s MammaPrint® Breast Cancer Risk-of-Recurrence Test Obtains Favorable Final Payment Determination from CMS for New, Unique Category 1 CPT Code	11/28/2017

Page 33 of 84